Episode Details
Back to EpisodesMultiple Sclerosis, Rituximab, Hypogammaglobulinemia and Risk of Infections
Published 1 year, 9 months ago
Description
Dr. Shuvro Roy and Dr. Annette Langer-Gould discuss the effective dose of rituximab and other B-cell depleting therapies in patients with multiple sclerosis, as well as important comorbidities to prevent infection risks.
Show reference: